Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
57.30
+0.96 (1.70%)
Jan 7, 2026, 11:41 AM EST
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
$631,163
Profits / Employee
$207,532
Market Cap
253.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
| Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
| Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
| Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
| Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
Novo Nordisk News
- 9 hours ago - Novo Nordisk (NVO) Gains as Oral Weight Loss Drug Wegovy Hits U.S. Pharmacies - GuruFocus
- 12 hours ago - Novo Nordisk Stock Climbs After Expanding Veeva Vault CRM Partnership - GuruFocus
- 12 hours ago - First Look: Nvidia, Ford, Novo Nordisk and Hyundai in Focus - GuruFocus
- 1 day ago - Ro CEO Zach Reitano talks launch of Wegovy's GLP-1 pill - CNBC
- 1 day ago - Should Investors Be Concerned About This Pharmaceutical Giant's Latest Clinical Trial? - The Motley Fool
- 1 day ago - European Stocks Rise as Novo Nordisk (NVO) Boosts Healthcare Sector - GuruFocus
- 1 day ago - Novo Nordisk (NVO) Rises on U.S. Launch of Oral Wegovy - GuruFocus
- 1 day ago - Novo Nordisk: Wegovy Pill Is Not A Game Changer - Seeking Alpha